LumiMeds
LumiMeds is a US telehealth platform offering personalised, affordable weight management and metabolic health care, including GLP-1 treatments and NAD+ injections, through licensed providers.
LumiMeds is a telehealth platform providing personalised, affordable long-term health care focused on weight management and metabolic health, delivered through licensed medical providers. The company operates in the United States and serves patients across the healthcare, telehealth, weight management, metabolic health and longevity/wellness verticals.
Its service offering combines secure, HIPAA-compliant telehealth consultations with treatment programmes. Patients receive tailored treatment plans and ongoing support from a care team. Treatments include GLP-1 injectable treatments and GLP-1/GIP combination injectable treatments for weight care, alongside NAD+ injections offered as part of wellness services.
Technically, the company works in the domains of telehealth, HIPAA-compliant digital health and digital health platform development. Its stated operating principles include patient-centred care built around personalised health plans, a focus on building lasting patient relationships, transparent pricing with no insurance requirements, and continued support from the care team.
